gemfibrozil has been researched along with Alloxan Diabetes in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil is a PPAR-α ligand that inhibits the progression of atherosclerosis in insulin resistance type 2 diabetes mellitus (IR type 2 DM)." | 3.79 | Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats. ( Kurmi, MK; Raikwar, SK; Sharma, AK; Srinivasan, BP, 2013) |
| " In a twelve-week study, chronic administration of 3b in db/db mice resulted in sustained glycemic control, to a greater extent than liraglutide and semaglutide." | 1.56 | Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents. ( Chen, X; Fu, J; Han, J; Li, C; Yang, Q; Yin, J; Zhou, F, 2020) |
| "Gemfibrozil treatment restored the endothelium-dependent responses to acetylcholine in diabetic rats." | 1.32 | Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta. ( Akin, FB; Ozansoy, G, 2004) |
| "Gemfibrozil treatment had no effect on blood glucose, plasma insulin and vessel antioxidant enzyme activity of diabetic animals." | 1.31 | Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. ( Akin, B; Aktan, F; Karasu, C; Ozansoy, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 2 |
| Maurya, RA | 2 |
| Sharma, S | 2 |
| Ahmad, P | 1 |
| Singh, AB | 1 |
| Bhatia, G | 2 |
| Srivastava, AK | 2 |
| Tripathi, VD | 1 |
| Srivastava, SP | 1 |
| Tamrakar, AK | 1 |
| Han, J | 1 |
| Fu, J | 1 |
| Yang, Q | 1 |
| Zhou, F | 1 |
| Chen, X | 1 |
| Li, C | 1 |
| Yin, J | 1 |
| Sharma, AK | 1 |
| Raikwar, SK | 1 |
| Kurmi, MK | 1 |
| Srinivasan, BP | 1 |
| Ozansoy, G | 2 |
| Akin, FB | 1 |
| Calkin, AC | 1 |
| Cooper, ME | 1 |
| Jandeleit-Dahm, KA | 1 |
| Allen, TJ | 1 |
| Akin, B | 1 |
| Aktan, F | 1 |
| Karasu, C | 1 |
7 other studies available for gemfibrozil and Alloxan Diabetes
| Article | Year |
|---|---|
Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dyslipidemias; Hypoglycemic Agents; Lipid M | 2009 |
Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Design; Dyslipidemias; Glycogen Phosphorylase; Hypogl | 2010 |
Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.
Topics: Albumins; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-R | 2020 |
Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats.
Topics: Adiponectin; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug | 2013 |
Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, | 2004 |
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.
Topics: Angiotensins; Animals; Apolipoproteins E; Atherosclerosis; Biomarkers; Diabetes Mellitus, Experiment | 2006 |
Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats.
Topics: Animals; Antioxidants; Aorta; Blood Glucose; Body Weight; Catalase; Cholesterol; Diabetes Mellitus, | 2001 |